Nature 2016-03-31

Nucleus accumbens D2R cells signal prior outcomes and control risky decision-making.

Kelly A Zalocusky, Charu Ramakrishnan, Talia N Lerner, Thomas J Davidson, Brian Knutson, Karl Deisseroth

Index: Nature 531 , 642-6, (2016)

Full Text: HTML

Abstract

A marked bias towards risk aversion has been observed in nearly every species tested. A minority of individuals, however, instead seem to prefer risk (repeatedly choosing uncertain large rewards over certain but smaller rewards), and even risk-averse individuals sometimes opt for riskier alternatives. It is not known how neural activity underlies such important shifts in decision-making--either as a stable trait across individuals or at the level of variability within individuals. Here we describe a model of risk-preference in rats, in which stable individual differences, trial-by-trial choices, and responses to pharmacological agents all parallel human behaviour. By combining new genetic targeting strategies with optical recording of neural activity during behaviour in this model, we identify relevant temporally specific signals from a genetically and anatomically defined population of neurons. This activity occurred within dopamine receptor type-2 (D2R)-expressing cells in the nucleus accumbens (NAc), signalled unfavourable outcomes from the recent past at a time appropriate for influencing subsequent decisions, and also predicted subsequent choices made. Having uncovered this naturally occurring neural correlate of risk selection, we then mimicked the temporally specific signal with optogenetic control during decision-making and demonstrated its causal effect in driving risk-preference. Specifically, risk-preferring rats could be instantaneously converted to risk-averse rats with precisely timed phasic stimulation of NAc D2R cells. These findings suggest that individual differences in risk-preference, as well as real-time risky decision-making, can be largely explained by the encoding in D2R-expressing NAc cells of prior unfavourable outcomes during decision-making.


Related Compounds

  • Pramipexole dihydr...

Related Articles:

Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum.

2015-04-01

[Pharmacol. Biochem. Behav. 131 , 1-5, (2015)]

Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.

2015-01-01

[PLoS ONE 10(3) , e0117698, (2015)]

De novo expression of dopamine D2 receptors on microglia after stroke.

2015-11-01

[J. Cereb. Blood Flow Metab. 35 , 1804-11, (2015)]

Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.

2015-03-01

[J. Pharmacol. Exp. Ther. 352(3) , 480-93, (2015)]

Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.

2013-07-01

[J. Affect. Disord. 149(1-3) , 319-25, (2013)]

More Articles...